# A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

> **NCT00327015** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1306 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** Saxagliptin
- **DRUG:** Saxagliptin
- **DRUG:** Metformin
- **DRUG:** Placebo
- **DRUG:** pioglitazone

## Key facts

- **NCT ID:** NCT00327015
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2007-11
- **Final completion:** 2008-12
- **Target enrollment:** 1306 (ACTUAL)
- **Last updated:** 2015-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00327015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00327015, "A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00327015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*